This overexpression was thought to be correlated with tumor stage and lymph node metastases [14, 15], and high expression of FXYD3 tended to result in an increased incidence of distant metastasis after patients underwent preoperative radiotherapy for rectal cancer. Here, FXYD3 is linked to metastatic malignant neoplasm in the lymph nodes.